Epsolay is an investigational topical cream that utilizes the Company’s patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules. The New Drug Application (NDA) ...

Epsolay is a topical cream that utilizes a patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules. Epsolay ® (benzoyl peroxide) cream is now available for the ...

NESS ZIONA, Israel & LAUSANNE, Switzerland--(BUSINESS WIRE)--Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, and Galderma, the world’s largest independent dermatology ...

NESS ZIONNA, Israel, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies (NASDAQ: SLGL), (“Sol-Gel”), today announced positive topline data for its open-label, long-term safety study, evaluating ...

NESS ZIONA, Israel, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Sol-Gel Technologies announced positive results of a ...

The FDA approved benzoyl peroxide 5% cream (Epsolay) for adults with inflammatory lesions of rosacea, Sol-Gel Technologies announced on Monday. Using silica-based microcapsules that create a barrier ...

NESS ZIONA, Israel, July 25, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (SLGL), a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 ...

Rosacea is a dermatologic condition affecting the centrofacial region (cheeks, chin, nose, and forehead), resulting in symptoms of facial flushing, swollen bumps on the skin surface, and a burning ...